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Limbal Fibroblasts Maintain Normal Phenotype
in 3D RAFT Tissue Equivalents Suggesting Potential
for Safe Clinical Use in Treatment of Ocular Surface Failure
Isobel Massie, PhD, Sarah B. Dale, PhD, and Julie T. Daniels, PhD, FSB
Limbal epithelial stem cell deficiency can cause blindness, but transplantation of these cells on a carrier such as
human amniotic membrane can restore vision. Unfortunately, clinical graft manufacture using amnion can be
inconsistent. Therefore, we have developed an alternative substrate, Real Architecture for 3D Tissue (RAFT),
which supports human limbal epithelial cells (hLE) expansion. Epithelial organization is improved when human
limbal fibroblasts (hLF) are incorporated into RAFT tissue equivalent (TE). However, hLF have the potential to
transdifferentiate into a pro-scarring cell type, which would be incompatible with therapeutic transplantation. The
aim of this work was to assess the scarring phenotype of hLF in RAFT TEs in hLE+ and hLE- RAFT TEs and
in nonairlifted and airlifted RAFT TEs. Diseased fibroblasts (dFib) isolated from the fibrotic conjunctivae of
ocular mucous membrane pemphigoid (Oc-MMP) patients were used as a pro-scarring positive control against
which hLF were compared using surrogate scarring parameters: matrix metalloproteinase (MMP) activity, de
novo collagen synthesis, a-smooth muscle actin (a-SMA) expression, and transforming growth factor-b (TGF-b)
secretion. Normal hLF and dFib maintained different phenotypes in RAFT TE. MMP-2 and -9 activity, de novo
collagen synthesis, and a-SMA expression were all increased in dFib cf. normal hLF RAFT TEs, although TGF-
b1 secretion did not differ between normal hLF and dFib RAFT TEs. Normal hLF do not progress toward a
scarring-like phenotype during culture in RAFT TEs and, therefore, may be safe to include in therapeutic RAFT
TE, where they can support hLE, although in vivo work is required to confirm this. dFib RAFT TEs (used in this
study as a positive control) may be useful toward the development of an ex vivo disease model of Oc-MMP.
Introduction
The cornea is located on the front of the eyeball andprovides a transparent window to the world. It is a
complex, avascular, multilayered tissue consisting of an
outermost epithelial cell layer, which protects the underly-
ing stroma, located anterior to the endothelium.1 Main-
tenance of the epithelium is crucial to corneal function and
sloughed epithelial cells are replaced by the progeny of
limbal epithelial stem cells (LESC). LESC reside within a
specialized niche environment, the limbus, located at the
vascularized border between the central cornea and con-
junctiva.2,3 Damage to the limbus and loss of LESC can lead
to ocular surface failure and blindness: the cornea becomes
vascularized and inflamed and conjunctival epithelial cells
migrate to cover the cornea.4
One treatment for LESC deficiency is transplantation of
cultured human limbal epithelial cells (hLE) on a carrier
such as human amniotic membrane (HAM). However, clin-
ical graft manufacture can be inconsistent.5–7 Additionally,
HAM is intrinsically biologically variable,8 supply can be
unreliable, and the tissue must be screened before use which
has led us, and others, to investigate alternative means of
transplanting hLE. Our approach is to utilize a tissue equiv-
alent (TE), Real Architecture for 3D Tissue (RAFT) that
consists primarily of Type 1 collagen.9
RAFT TEs are produced by gently dehydrating collagen
hydrogels and we have previously demonstrated that RAFT
TE is excellent for hLE expansion. RAFT TEs may also be
cultured at the air/liquid interface (airlifted) to promote
epithelial stratification, suggesting that RAFT TEs may be
clinically effective toward the treatment of LESC deficien-
cy.9 The organization of epithelium cultured on RAFT TE
and deposition of basement membrane proteins is further
enhanced when pre-expanded human limbal fibroblasts
(hLF) are incorporated into RAFT TEs.9 In native limbus,
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hLE are supported by cells located proximally in the un-
derlying stroma and so the supportive role that hLF play in
RAFT TEs is perhaps unsurprising as this culture format
mimics the in vivo arrangement.1
In vivo, stromal keratocytes (specialized corneal fibro-
blasts) are normally quiescent.10 However, these keratocytes
can become activated following epithelial injury and asso-
ciated cytokine release. These activated cells play a role in
wound healing and remodel the damaged stroma, restoring
transparency. However, these also have the potential to
transdifferentiate further to a pro-scarring phenotype. hLF
proliferate in vitro, suggesting some degree of activation,
which highlights the possibility of further transdifferentia-
tion into a pro-scarring phenotype.
The overall aim of the RAFT therapy is to treat LESC de-
ficiency and althoughwe know that hLF support hLE in RAFT
TEs, the potential risk of hLF transdifferentiation meant
that further characterization of hLF was needed. The aim of
the current work was to investigate whether or not the pre-
expanded hLF utilized in RAFT TEs exhibit any pro-scarring
characteristics, to determine whether or not they may be safe
for clinical use. To do so, a pro-scarring positive control cell
type was required against which normal hLF could be com-
pared. The ideal positive control would be pro-scarring limbal
fibroblasts, but such cells are unavailable as to biopsy them
would cause further damage to the patient. Instead, we chose to
use a conjunctival fibroblast population isolated from ocular
mucousmembrane pemphigoid (Oc-MMP) patients. Oc-MMP
is a devastating autoimmune disease that can result in blind-
ness due to episodes of inflammation followed by aggressive
scarring of the conjunctiva.11 Oc-MMP conjunctival fibro-
blasts are known to maintain some scarring characteristics
in vitro12 and are found in very close proximity to normal hLF
and so we chose to use these as our positive control cell type
(for clarity, the different cell types used in this study are
summarized in Table 1). The scarring characteristics of normal
hLF in RAFT TEs were assessed in the presence and absence
of hLE, before and after airlifting.
Materials and Methods
Chemicals
All reagents were obtained from Life Technologies, un-
less stated otherwise.
Human cell isolation and culture
Normal donor tissue. Cadaveric donor corneal rims with
appropriate research consent were obtained from the Moor-
fields Lions Eye Bank (United Kingdom). Ethical permission
for this study was obtained from the Research Ethics Com-
mittee (United Kingdom) (Ref. No. 10/H0106/57-11ETR10).
Corneas were stored at 4C in Optisol (Chiron Ophthalmics,
Inc.) after enucleation and before hLE and normal hLF
isolation.
Diseased donor tissue (for positive control). Diseased
conjunctival biopsies were taken from patients with biopsy
positive (direct immunofluorescence) Oc-MMP, presenting
with active conjunctival scarring. Ethical permission was
obtained from the Research Ethics Committee (United
Kingdom) (Ref No. 10/H0311/40). Biopsies were stored at
4C in L-15 medium (Leibovitz’s) until diseased fibroblast
(dFib) isolation.
Isolation and culture of normal hLE. hLE were isolated
and cultured as described previously.9 Briefly, dispase di-
gestion and mechanical scraping was used to isolate hLE
from donor corneal rims. hLE were cultured in corneal
epithelial culture medium (CECM) on growth-arrested 3T3-
J2 cells and passaged using 0.5% trypsin-EDTA before
seeding onto RAFT TE at passage 1.
Isolation and culture of normal hLF. After hLE isolation,
the remaining scleral–limbal rim quarters were trimmed of
excess sclera and cut into three pieces. These were placed in
explant culture with hLF culture medium (DMEM basal
medium, 10% fetal bovine serum, 1% AA) in a humidified
5% CO2 in air incubator at 37C. Explant cultures were
maintained until hLF outgrowth was observed before being
passaged using 0.05% trypsin-EDTA. hLF were not used
beyond passage 6.
Isolation and culture of diseased (positive control) human
conjunctival fibroblasts. Biopsies were placed in 1.2 IU/mL
dispase II for 1min and epithelium scraped away. Small cuts
were made in the biopsies to encourage dFib outgrowth and
biopsies were placed in explant culture with hLF culture
medium in a humidified 5% CO2 in air incubator at 37C.
hLF medium was changed once per week until outgrowth
was observed. dFib were not used beyond passage 6.
Preparation of RAFT TE
Normal hLF or dFib were suspended at 5.8 · 104/mL final
collagen mix in hLF medium. Collagen mix was prepared
by mixing 1 part 10· MEM, 8 parts 2mg/mL sterile rat-tail
Type I collagen (TAP BioSystems), and 0.59 parts neu-
tralizing solution (TAP BioSystems) to achieve a pH *7.2.
Fibroblast cell suspension (0.41 parts) was added, mixed,
and left on ice for 30min to allow any small bubbles to
disperse. This mixture (2.4mL) was pipetted into each well
of a 24-well plate (Greiner Bio-One) and placed on a heater
(TAP BioSystems) at 37C for 30min to undergo fibrillogen-
esis. Water was wicked away from the collagen hydrogels
through application of hydrophilic porous absorbers (TAP
BioSystems).13 After 30min, the absorbers were removed and
2mL of hLF medium was added. After 2 h, if hLE were
Table 1. Cell Types Described in This Article
Abbreviation Meaning Definition
hLE Human limbal
epithelial cell
Limbal epithelial cell
isolated from the
limbus of normal
donors
Normal
hLF
Normal human
limbal
fibroblast
Stromal cell isolated
from the limbus
of normal donors
dFib Diseased
fibroblast
Cell with pro-scarring
characteristics isolated
from the conjunctiva
of ocular mucous
membrane pemphigoid
patients
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required, 5.8 · 105 hLE suspended in 2mL of CECM were
seeded onto each RAFT TE (when not required, hLF me-
dium was replaced with 2mL of CECM). RAFT TEs were
maintained in a humidified 5% CO2 in air incubator at 37C,
with medium changes three times per week, for 2 weeks.
Airlifting to induce stratification of hLE
To determine whether the scarring profiles of normal hLF
was affected by the presence of a monolayer of epithelial
cells or multilayered epithelium, some RAFT TEs were
airlifted.
RAFT TEs were carefully transferred to a cell culture
insert (Millipore) in six-well plates using a spatula and
forceps. CECM (800mL) was added underneath each insert
to maintain hLE at the air–liquid interface. Airlifted RAFT
TEs were maintained using CECM in a humidified 5% CO2
in air incubator at 37C for 1 week.
Preparation of conditioned medium
RAFT TEs containing either normal hLF or dFib, with
and without hLE, and with and without airlifting were wa-
shed six times with phosphate buffered saline (PBS) and
then serum-starved for 18 h in 2mL of serum-free medium
(0.1% BSA [Sigma-Aldrich], 1% AA). Serum starving was
necessary as the serum in CECM used to culture all RAFT
TEs contains growth factors and enzymes that may impact
on quantitative analysis. Acellular (no fibroblasts or hLE)
RAFT TEs were included as negative controls. Conditioned
medium was collected, aliquoted, and stored at - 80C until
analysis.
Matrix metalloproteinase activity
Matrix metalloproteinase (MMP) activity is associated
with matrix remodeling and cell migration and so increased
MMP activity would suggest presence of an activated pro-
scarring cell type.
Zymography. Gelatin zymography was used to assess
MMP-9 and -2 activities. Conditioned medium (5 mL) was
mixed 1:1 with sample buffer and loaded onto a zymogram
gel. Electrophoresis was performed at 125V for 90min. The
gel was incubated with zymogram renaturing buffer and the
developing buffer as per the manufacturer’s instructions.
The next day, the gel was stained with 0.01% Coomassie
Blue (Bio-Rad) in 40% ethanol/10% acetic acid for 30min
before destaining, using 10% ethanol/7.5% acetic acid for
1 h. A photo was taken for qualitative evaluation.
Only 13 samples could be run on each gel and so for
qualitative comparison between hLE - and hLE + RAFT
TEs, and nonairlifted and airlifted RAFT TEs, samples from
each single experiment (either normal hLF or dFib) were
compared on one gel. To compare normal hLF and dFib
directly, conditioned medium from each separate experi-
ment was pooled and compared on one gel (either from
airlifted or nonairlifted RAFT TEs).
Enzyme-linked immunosorbent assay. An enzyme-
linked immunosorbent assay (ELISA) kit (DMP100; R&D
Biosystems) was used to quantify MMP-1 secretion from
conditioned medium according to the manufacturer’s in-
structions. Optical density (450 nm) was measured using a
plate reader (MTX Lab Systems, Inc.) and data analyzed
using the Excel Software. Appropriate blanks were included
in each experiment.
Transforming growth factor-b1 secretion
Transforming growth factor-b1 (TGF-b1) is a soluble
factor that can trigger transdifferentiation of quiescent fi-
broblasts into an activated pro-scarring cell type and so
increased levels of TGF-b1 would indicate an increased
likelihood of pro-scarring cells.
An ELISA kit (KAC1688) was used to quantify TGF-b1 in
conditioned medium according to the manufacturer’s in-
structions. Conditioned medium was concentrated five times
before assay using centrifugal filters (Millipore). Optical
density (450nm) was measured and analyzed as above.
Collagen production
De novo collagen production is associated with stromal
and basement membrane remodeling, characteristic of pro-
scarring cells; increased collagen synthesis would, therefore,
indicate a greater number of activated, pro-scarring cells.
Collagen production in conditioned medium samples was
quantified using a Sircol assay kit (Biocolor). All condi-
tioned media samples were concentrated using the optional
isolation and collagen concentration step included within the
kit. Optical density (555 nm) was measured and analyzed as
above.
Wounding hLE on RAFT TE
To determine whether or not wounding the epithelium
affected normal hLF phenotype, hLE on RAFT TEs were
wounded and normal hLF characterized using immunohis-
tochemistry.
Nonairlifted normal hLF RAFT TEs with hLE were
wounded by the application of heptanol-soaked paper discs
for 1min. After wounding, RAFT TEs were returned to the
airlifting culture to mimic in vivo conditions (i.e., the front
of the eye). RAFT TEs were fixed for immunohistochem-
istry either immediately before or 6 days after wounding.
Wholemount immunohistochemistry against
a-smooth muscle actin
a-Smooth muscle actin (a-SMA) expression suggests the
presence of myofibroblasts and that a contractile scarring
response is underway.
Creation of immunohistochemistry positive control a-SMA-
expressing cells. Normal hLF or dFib were seeded into
200mL tethered collagen gels (i.e., produced as RAFT TEs,
but without application of absorbers) and cultured for 48 h to
force transdifferentiation into myofibroblasts under me-
chanical tension,14,15 before fixing for 1 h in 4% parafor-
maldehyde (PFA; VWR) in PBS.
Wholemount immunohistochemistry staining. RAFT TEs
were fixed in 4% PFA for 30min. Samples were washed
with PBS and blocked for 1 h in 5% normal goat serum with
0.25% Triton X. Samples were washed with PBS before
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simultaneous application of a Cy3-conjugated a-SMA an-
tibody (1:200; Sigma-Aldrich) and FITC-phalloidin
(1:1000; Sigma-Aldrich) in blocking buffer for 1 h in the
dark. Negative control samples were obtained by the
omission of Cy3-conjugated antibody. Samples were wa-
shed with PBS and transferred onto microscope slides.
Nuclei were counterstained using DAPI mounting medium
(Vector Labs). Coverslips were applied before analysis on a
LSM 710 microscope (Zeiss).
Three fields of view on each sample were captured at
40 · magnification for qualitative evaluation of a-SMA
expression. Using the micrographs, cells were identified as
either positive or negative for a-SMA and scored as follows:
0–1 positive cells out of 10 were scored as - , 2–4 positive
cells out of 10 as + , 5–7 positive cells out of 10 as ++ , and
8 or more positive cells out of 10 as +++ .
Statistics
Within each condition within each experiment, three
RAFT TEs were tested. Each experiment was performed in
triplicate using cells isolated from six different fibroblast
donors (i.e., three normal hLF and three dFib) and three
different hLE donors. Data are presented as averages of three
individual experiments– standard deviation. GraphPad Prism
was used for statistical analyses. Where two groups were
compared, unpaired t-tests were used. Where more than two
groups were compared, a one-way analysis of variance
(ANOVA) was used. Tukey’s multiple comparisons test was
used to test for individual comparisons following ANOVA.
p< 0.05 was considered statistically significant.
Results
MMP-9 and MMP-2 activity is increased
in dFib compared with normal hLF, and is affected
by the presence of hLE and by airlifting
MMP activity in both normal hLF and dFib RAFT TEs
was affected by the presence of hLE and by airlifting (Fig.
1A). Pro MMP-9 (92 kDa) was only found when hLE were
present on RAFT TE. MMP-9 activity was lower in airlifted
RAFT TEs compared with nonairlifted RAFT TEs. Both pro
MMP-2 (66 kDa) and active MMP-2 (62 kDa) activity was
found in all RAFT TEs. The presence of hLE reduced
MMP-2 activity in both normal and dFib RAFT TEs. Con-
versely, airlifting increased MMP-2 activity in both normal
and dFib RAFT TEs.
When MMP activity in normal hLF and positive control
dFib RAFT TEs was compared directly (Fig. 1B) on the
same zymogram before airlifting, activities of pro MMP-9
and both forms of MMP-2 was increased in dFib RAFT TEs
compared with normal hLF RAFT TEs. However, after
airlifting, there were no differences in MMP activities be-
tween normal hLF and dFib RAFT TEs.
Pro MMP-1 secretion did not differ between
normal hLF and dFib RAFT TEs and was unaffected
by the presence of hLE or by airlifting
There was no significant difference in the production of
pro MMP-1 in positive control dFib RAFT TEs compared
with normal hLF RAFT TEs in the presence or absence of
hLE or airlifting (Fig. 2).
Collagen production was increased from dFib
RAFT TEs compared with normal hLF RAFT TEs
Collagen production from positive control dFib RAFT TEs
was approximately three-fold greater than from normal hLF
RAFT TEs ( p< 0.05, except for nonairlifted RAFT TEs
without hLE) (Fig. 3). For all dFib RAFT TEs, over 7mg of
collagen was measured in conditioned medium, compared
with below 4mg of collagen for normal hLF RAFT TEs. For
RAFT TEs populated with normal hLF, collagen production
was unaffected by the presence of hLE or by airlifting (Fig.
3). Collagen production was significantly reduced from air-
lifted, dFib RAFT TEs with hLE compared with nonairlifted
dFib RAFT TEs with hLE ( p< 0.05) from *14 to *7mg.
a-SMA expression was increased in dFib RAFT TEs
compared with normal hLF RAFT TEs
The immunohistochemistry positive control a-SMA-
expressing cells in RAFT TEs (forced transdifferentiation
FIG. 1. MMP-2 and MMP-9 activity. MMP-2 and MMP-9
activity was measured from conditioned medium by gelatin
zymography. The three bands on each zymogram corre-
spond to pro MMP-9 (92 kDa), pro MMP-2 (66 kDa), and
active MMP-2 (62 kDa) as labeled on the right of each gel.
(A)MMP activity from RAFT TEs made with either normal
hLF (top) or dFib (bottom) with or without hLE and from
nonairlifted and airlifted RAFT TEs (AL). Each lane rep-
resents conditioned medium collected from a single RAFT
TE construct within one experiment. The zymograms shown
in (A) are representative of two further experimental re-
peats. (B) Comparison between MMP activities from RAFT
TEs made with either normal hLF (N) or dFib (D) with hLE
or without hLE. MMP activity was compared from non-
airlifted (top) or airlifted (bottom) RAFT TEs. Each lane
represents conditioned medium pooled from three separate
experiments for each RAFT TE condition. In both (A, B),
the right hand side lane represents the negative control
(conditioned medium was collected from acellular RAFT
TEs). dFib, diseased fibroblasts; hLE, human limbal epi-
thelial cells; hLF, human limbal fibroblasts; MMP, matrix
metalloproteinase; RAFT, real architecture for 3D tissue;
TEs, tissue equivalents. Color images available online at
www.liebertpub.com/tec
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under mechanical tension) (Fig. 4A) exhibited a dendritic
morphology with strong a-SMA expression. In the negative
control RAFT TEs (antibody omitted) (Fig. 4B), no positive
a-SMA staining was observed.
In RAFTTEs populated with normal hLF (Fig. 4C–F), there
was very little a-SMA expression. However, greater numbers
of normal hLFwere observed in hLE- RAFTTEs (Fig. 4C, E)
and these hLF appeared disorganized with irregular cell
morphologies. Normal hLF in hLE+ RAFT TEs (Fig. 4D, F)
appeared sparser and were more regular in morphology.
In positive control dFib RAFT TEs (Fig. 4G–J) many more
cells expressed a-SMA compared with normal hLF RAFT
TEs. Again, greater numbers of dFib were present in the
hLE- RAFT TEs (Fig. 4G, I) compared with hLE+ RAFT
TEs (Fig. 4H, J). Although nearly all of these dFib expressed
a-SMA, they did not exhibit the typical square myofibroblast
morphology, and there was little evidence of stress fiber as-
sembly. In hLE- RAFT TEs (Fig. 4H, J), a smaller proportion
of dFib expressed a-SMA, but those that did displayed a more
typical square myofibroblast morphology, with evidence of
stress fiber assembly. These results are summarized in Table 2.
TGF-b1 secretion was similar from both normal
hLF RAFT TEs and dFib RAFT TEs
TGF-b1 secretion was similar from normal hLF and pos-
itive control dFib populated RAFT TEs (Fig. 5). However, for
both types of fibroblast, there was a significant trend toward
decreased TGF-b1 secretion from airlifted RAFT TEs com-
pared with nonairlifted RAFT TEs, regardless of the presence
or absence of hLE ( p< 0.05). Before airlifting, TGF-b1 was
quantified at above 100 pg/mL, reduced to below*50pg/mL
after airlifting for both normal hLF and dFib.
Epithelial injury did not cause activation of normal
hLF in RAFT TEs to express a-SMA
Before hLE wounding, there was very little a-SMA ex-
pression by normal hLF in RAFT TE (Fig. 6A) and no
evidence of stress fiber assembly, in agreement with the
results described in Figure 4. Six days postwounding, there
were similarly low levels of a-SMA expression, and cell
morphology remained unaltered (Fig. 6B).
Discussion
LESC deficiency can cause ocular surface failure and
blindness. We have developed RAFT TEs that could be used
as a carrier to transplant hLE. hLE organization and base-
ment membrane production is enhanced on RAFT TEs when
hLF are present.9 However, hLF have the potential to dif-
ferentiate into myofibroblast-like cells. The aim of this study
was to determine if normal hLF in RAFT TEs are pro-
scarring or not, to determine whether hLF may be safe to
transplant alongside hLE.
We chose MMP activities, de novo collagen synthesis, a-
SMA expression, and TGF-b secretion as surrogate scarring
parameters. Significant upregulation of any/all of these
would suggest that the fibroblasts might be becoming
myofibroblast-like16–18 and similar to those observed as part
of a normal wound healing response. Normally, when no
longer needed, myofibroblasts should apoptose to restore
quiescence to the stroma.19 However, this is incorrectly
regulated in Oc-MMP patients and the resultant persistent
scarring response can cause blindness. dFib from Oc-MMP
patients are known to retain pro-scarring parameters in 2D
cultures (proliferation, migration, collagen contraction and
synthesis, MMP, and eotaxin expression are all increased in
dFib compared with normal conjunctival fibroblasts)12 so
we exploited dFib as a positive control comparator for
normal hLF. As stated earlier, unfortunately pro-scarring
limbal fibroblasts are unavailable as biopsying them would
be detrimental to the patient.
FIG. 3. Collagen production. Collagen production was
measured from conditioned medium by the Sircol colorimetric
assay. RAFT TE constructs contained either normal hLF
(black bars) or dFib (gray bars). Conditioned medium was
collected from RAFT TEs with or without hLE from non-
airlifted and airlifted (AL) RAFT TEs. *p< 0.05. n= 3–SD.
FIG. 2. Pro MMP-1 secretion. Pro MMP-1 secretion was
measured from conditioned medium by ELISA. RAFT TE
constructs contained either normal hLF (black bars) or dFib
(gray bars). Conditioned medium was collected from RAFT
TEs with or without hLE from nonairlifted and airlifted
(AL) RAFT TEs. None of these results are statistically
significant. n= 3 – SD. ELISA, enzyme-linked immunosor-
bent assay; SD, standard deviation.
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MMP activity is associated with matrix remodeling and
cell migration. (MMP-1 is required to cleave the collagen
triple helix so that MMP-2 or -9 can access their respective
gelatin substrate cleavage sites). We found that MMP-9 and
-2 activities were greater for dFib than for normal hLF before
airlifting, which is the first indicator that normal hLF remain
less activated than dFib in RAFT TEs, which is encouraging.
More specifically, MMP-9 is primarily associated with
basement membrane remodeling by and migration of, hLE,
(reviewed in Sivak and Fini20), and in agreement, we only
saw MMP-9 when hLE were present. MMP-9 activity sug-
gests that the hLE are remodeling basement membrane/
migrating, which is to be expected given that these cells are
establishing a new culture on RAFT TEs. Interestingly,
MMP-9 activity was decreased following airlifting. This
suggests that the requirement for further remodeling (and
MMP-9) was reduced at this later stage of culture when,
possibly, hLE are more established.
Conversely, MMP-2 is primarily concerned with stromal
remodeling by fibroblasts (reviewed in Sivak and Fini20). The
upregulation of MMP-2 by both normal hLF and dFib fol-
lowing airlifting suggests that both are continuing to remodel
the RAFT TE at this stage (perhaps so as to achieve a closer
resemblance to native stroma). Interestingly, MMP-2 activity
FIG. 4. a-SMA expression. Fi-
broblast expression of a-SMA
(red) in RAFT TE constructs was
observed using wholemount im-
munohistochemistry. RAFT TE
constructs were also stained for
phalloidin (green) and nuclei were
counterstained using DAPI (blue).
The positive (forced differentiation
under mechanical tension) and
negative (omission of anti-a-SMA
antibody) controls are shown in (A,
B), respectively (top). (C–F)
Staining of normal hLF within
RAFT TE (middle). (G–J) Staining
of dFib within RAFT TE (bottom).
(D, F, H, J) hLE + RAFT TEs (C,
E, G, I: hLE - RAFT TEs). (E, F,
I, J) Airlifted RAFT TEs (C, D, G,
H: nonairlifted RAFT TEs). All
images are representative of three
fields of view captured per condi-
tion per experiment. Scale bars:
50 mm. a-SMA, a-smooth muscle
actin. Color images available on-
line at www.liebertpub.com/tec
Table 2. Summary of a-SMA Expression
in Normal hLF and dFib RAFT TEs
Non-AL,
hLE-
Non-AL,
hLE +
AL,
hLE-
AL,
hLE +
Normal hLF - - - -
dFib +++ + +++ +
- indicates 0–1 a-SMA positive cells out of 10.
+ indicates 2–4 a-SMA positive cells out of 10.
+++ indicates 8 or more a-SMA positive cells out of 10.
This scoring system is described in the Materials and Methods
section.
AL, airlifted; a-SMA, a-smooth muscle actin; dFib, human
conjunctival fibroblasts isolated from donors with ocular mucous
membrane pemphigoid; hLE, human limbal epithelial cells; hLF,
human limbal fibroblasts; RAFT, real architecture for 3D tissue;
TEs, tissue equivalents.
FIG. 5. TGF-b1 secretion. TGF-b1 secretion was measured
from conditioned medium by ELISA. RAFT TE constructs
contained either normal hLF (black bars) or dFib (gray bars).
Conditioned medium was collected from RAFT TEs with or
without hLE from nonairlifted and airlifted (AL) RAFT TEs.
*p< 0.05. n= 3–SD. TGF-b1, transforming growth factor-b1.
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was suppressed by the presence of hLE for both fibroblast
types, suggesting that the presence of hLE quietens the acti-
vated phenotype. Potentially, without hLE, the lack of cross-
talk deceives the fibroblasts into experiencing an artificial
wounding environment, thus promoting the activated pheno-
type. To treat LESC deficiency, we would want to transplant
RAFT TEs with hLE and so this finding is encouraging.
Collagen production is also associated with stroma and
basement membrane remodeling.21,22 Again, we observed
greater collagen production from dFib RAFT TEs when
compared with normal hLF RAFT TEs, further suggesting
that normal hLF are less activated than dFib. For normal
hLF, the amounts of collagen produced were unaffected by
the presence or absence of hLE or by airlifting. For dFib, we
found that collagen production was decreased after air-
lifting, compared with before. This appears counterintuitive
to MMP-2 activities (which were increased after airlifting),
but this may reflect that the RAFT TE is simply being re-
modeled at this stage of culture, without a requirement for
continual deposition of new collagen.
The presence of myofibroblasts suggests a contractile
scarring response is underway. Myofibroblasts appear larger
and squarer than fibroblasts, with contractile stress fibers
and have altered gene expression patterns, notably upregu-
lation of a-SMA.23–26 Transdifferentiation to myofibroblasts
is mediated by mechanical stress27,28 (as exploited to achieve
our a-SMA positive controls at this point) and/or cytokine
release following injury.29,30
We found higher levels of a-SMA expression in dFib than
normal hLF, which in agreement with MMP activity and
collagen production data, suggests that normal hLF are less
activated than dFib in RAFT TEs. However, a-SMA-positive
dFib in hLE - RAFT TEs did not display the typical myo-
fibroblast morphology, but instead appeared more proto-
myofibroblast-like (the intermediate cell type between
fibroblasts and myofibroblasts).31,32 Potentially, the differ-
entiation process was unable to complete within the 2–3 week
culture period, and/or entrapment within RAFT TEs affects
the transdifferentiation process.
Immunohistochemistry also revealed that for both dFib
and normal hLF fibroblast cell density within RAFT TEs
was decreased when hLE were present. Furthermore for
dFib, we found that a-SMA expression was suppressed by
hLE. Decreased a-SMA expression suggests reduced acti-
vation when hLE are present, compared with when they are
absent (comparably with MMP-2 activity). Again, as we
would want to transplant RAFT TE with hLE, that hLE
additionally suppress a-SMA expression is favorable.
That fibroblast cell density is affected by hLE is impor-
tant with respect to MMP activity as the observed differ-
ences may result from differing fibroblast numbers.
However, the differential expression of a-SMA suggests
that hLE do impact on fibroblast phenotype, presumably as a
result of crosstalk (or lack of). Previous work demonstrating
that hLF enhance hLE phenotype in RAFT TEs provides
evidence of such crosstalk.9 Fibroblast/epithelial crosstalk
has also been shown to occur in another similar 3D format
(collagen hydrogels).33 This further corroborates the possi-
bility that fibroblast phenotype may be affected by, and alter
in response to, hLE in RAFT TE.
As a final surrogate scarring parameter, we looked at
TGF-b1 secretion. TGF-b1 can trigger transdifferentiation
of keratocytes into myofibroblasts in vivo,34–36 but also in
3D tissue-engineered constructs similar to RAFT TE,33,37
and so it was expected that higher levels of TGF-b1 would
be found in dFib RAFT TEs than normal hLF RAFT TEs.
However, we did not find this to be the case and, in fact, the
levels of TGF-b1 from dFib and normal hLF RAFT TEs
were almost identical.
There are a number of alternative soluble factors (not
investigated in this study) that could account for the ob-
served differences between normal hLF and dFib. Inter-
leukins 4 and 5, and interferon-g have all been implicated in
Oc-MMP patients, instead of TGF-b.38 Additionally, in
previous studies where TGF-b expression was found to be
increased in Oc-MMP tissue over normal tissue, tissue was
biopsied and immediately fixed for immunohistochemistry,
which is not comparable with this study.34–36
FIG. 6. Normal hLF response in RAFT TE to hLE wound. Expression of a-SMA (red) in normal hLF in nonairlifted,
hLE + RAFT TE constructs was observed by wholemount immunohistochemistry. RAFT TE constructs were also stained
for phalloidin (green) and nuclei were counterstained using DAPI (blue). RAFT TE constructs were stained either im-
mediately before (A), or 6 days after (B), wounding. Images are representative of five fields of view captured per condition
per experiment. Scale bars: 50 mm. Color images available online at www.liebertpub.com/tec
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Interestingly, for both normal hLF and dFib RAFT TEs,
TGF-b1 secretion was reduced after airlifting. Significant
manipulation of both fibroblast and epithelial cells (including
culture in both 2D and in 3D) is required to produce RAFT
TEs, and this may promote a wounding phenotype, tran-
siently increasing TGF-b1 expression (i.e., before airlifting
only). This may also, temporarily, mask any differences in
TGF-b expression between normal hLF and dFib.
The reduction in TGF-b1 expression after airlifting could
also provide mechanistic evidence for the decreased MMP-9
activity and collagen production after airlifting. Possibly,
secreted factors from a more mature epithelium (i.e., airlifted)
are less stimulatory than those from a growing epithelium
(i.e., nonairlifted). This has been demonstrated previously:
when fibroblasts were exposed to conditioned medium taken
from a growing epithelium, migration and contraction was
increased compared with fibroblasts exposed to conditioned
medium from mature epithelium,39 again highlighting the
importance of crosstalk between stromal and epithelial cells.
In summary, normal hLF remain relatively quiescent in
RAFT even as dFib remain more activated. This maintenance
of in vivo characteristics in vitro in RAFT TEs is important.
First, in the context of treating LESC deficiency, these data
suggest that RAFT TE containing normal hLF may be suit-
able for transplant alongside hLE, unlike dFib. Furthermore,
normal hLF are quietest in airlifted, hLE+ RAFT TEs. Ob-
viously, when attempting to treat LESC deficiency, we would
want to transplant RAFT TEs with hLE and our data suggests
that normal hLF may be safe(st) to use when hLE are present.
Additionally, we found no upregulation of a-SMA expression
by normal hLF in RAFT TE following hLE wounding. This
was an unexpected result, as epithelial injury is known to
trigger myofibroblast formation in vivo.30 It would, therefore,
seem that, in vitro at least at this stage, there is no evidence to
suggest that hLF are pro-scarring, which is encouraging.
However, there are a number of possible caveats to this: first,
the time scale of the experiment could have been too short
and/or there was insufficient time for TGF-b to accumulate
(due to regular media changes) or the lack of direct contact
between epithelial and stromal cells in RAFT TEs limits
potential for transdifferentiation. In vivo studies will be re-
quired to determine whether or not normal hLF remain qui-
escent posttransplantation where (higher concentrations of)
other soluble factors and cytokines are present, which may
affect hLF differently. Nevertheless, these in vitro findings
are encouraging.
Although not the main purpose of this study, that dFib
maintain an activated phenotype in RAFT TEs, is also of
interest as this suggests the potential use of RAFT TE as a
3D ex vivo disease model of Oc-MMP that could be used to
test anti-scarring therapies. This is useful as an in vitro
disease model of Oc-MMP is not currently in existence.
Conclusions
We assessed the scarring phenotype of normal hLF within
RAFT TEs using MMP activity, de novo collagen synthesis,
a-SMA expression, and TGF-b secretion as surrogate scar-
ring parameters. We used dFib isolated from Oc-MMP pa-
tients as a positive control. We found that the two fibroblast
types displayed very different phenotypes in RAFT TE:
normal hLF remained quiescent by comparison with dFib
meaning that there is not currently any reason to suggest that
these cells may be unsafe to use clinically, although in vivo
work is required to confirm this. As dFib maintained their
activated, pro-scarring phenotype in 3D RAFT TEs, these
could be utilized as an ex vivo disease model of Oc-MMP.
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